NeurTX

NeurTX, spun out from Weinberg Medical Physics (WMP), is pioneering a noninvasive, office-based MRI-guided Transcranial Magnetic Stimulation (TMS) system aimed at regenerating and myelinating damaged brain tracts. This innovative technology also facilitates the tomographic delivery of drugs and genes across the blood-brain barrier (BBB), with real-time monitoring of location, dose, and response. NeurTX operates in the medical device market, primarily serving healthcare providers and research institutions focused on neurological conditions. The business model revolves around the development and eventual commercialization of its MRI-guided TMS system, generating revenue through device sales, licensing agreements, and potential partnerships. Although the product is not yet FDA-approved, the company leverages WMP's extensive expertise in medical imaging and successful track record in launching FDA-cleared devices.

Keywords: MRI-guided TMS, brain tract regeneration, drug delivery, blood-brain barrier, noninvasive, neurological conditions, medical device, real-time monitoring, FDA clearance, healthcare providers.